MedPath

LEPU BIO-B

LEPU BIO-B logo
🇨🇳China
Ownership
Public, Subsidiary
Established
2018-01-19
Employees
491
Market Cap
-
Website
http://www.lepubiopharma.com
Introduction

Lepu Biotechnology Co., Ltd. is an innovative biopharmaceutical company based in China and focusing on the field of cancer treatment for the world. We have developed a strong product pipeline focusing on oncolog-focused drug candidates, including clinical and preclinical ADCs, oncolytic virus drugs, and immunotherapy. We plan to commercialize the product pipeline domestically by building a professional sales and marketing team, and promote the product pipeline to overseas markets such as the US and Europe through cooperation with overseas companies.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Pucotenlimab Injection

Product Name
普佑恒
Approval Number
国药准字S20220022
Approval Date
Jul 19, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.